Leading the way to safer medication
 Crosscheck  Recommender

ABILIFY

Found in: Austria Australia Canada Cyprus Spain France Netherlands Singapore United Kingdom United States

Active Ingredients

#
Chemical substance
Description
1
Aripiprazole

It has been proposed that aripiprazole’s efficacy in schizophrenia and Bipolar I Disorder is mediated through a combination of partial agonism at dopamine D2 and serotonin 5-HT1A receptors and antagonism of serotonin 5-HT2A receptors.

ATC Classification

Code
Title
Category
N05AX12
Aripiprazole
N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics

Product Monographs

Monograph
Type
Country
ABILIFY Tablet
MPI, EU: SmPC
ABILIFY Solution for injection
MPI, EU: SmPC

Identifiers

Authority
Identifier(s)
FDA, National Drug Code (US)
Identifier(s): 55289-251, 59148-006, 59148-007, 59148-008, 59148-009, 59148-010, 59148-011, 59148-029, 59148-030, 59148-031, 59148-032, 59148-033, 59148-034
Health Products and Food Branch (CA)
Identifier(s): 02322374, 02322382, 02322390, 02322404, 02322412, 02322455, 02420864, 02420872
Health Sciences Authority (SG)
Identifier(s): 13006P, 13007P, 13008P, 15192P
Pharmaceutical Benefits Scheme (AU)
Identifier(s): 10219W, 10224D, 8717T, 8718W, 8719X, 8720Y
Z-Index G-Standaard PRK (NL)
Identifier(s): 112852, 128856, 75248, 75256, 75264, 86118
Base de données publique des médicaments (FR)
Identifier(s): 60599533, 61815891, 64055988, 64224801, 65198099, 66706942, 66791654, 68729480, 69641873
Centro de información online de medicamentos de la AEMPS (ES)
Identifier(s): 04276002, 04276007, 04276007IP, 04276007IP1, 04276007IP2, 04276007IP3, 04276012, 04276012IP, 04276012IP3, 04276025, 04276028, 04276034, 04276036, 04278012IP1, 113882001, 113882002